Sagimet Biosciences Inc.
USD7.70
-0.10 (-1.22%)
CEO
David Happel
IPO Date
2023-07-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.70
Prev. Close
$7.79
Day Low
$7.61
Day High
$7.73
52W Low
$4.50
52W High
$11.41
Market Cap
$0.25B
Volume
0.03M
| 39,567 |
| $6.48 |
| 15 Jun 2026 | Jarrett Jennifer | director | A-Award | Acquired | 39,567 | $6.48 |
| 15 Jun 2026 | GRAMMER ELIZABETH A | director | A-Award | Acquired | 39,567 | $6.48 |
| 15 Jun 2026 | Kemble George | director | A-Award | Acquired | 39,567 | $6.48 |
| 15 Jun 2026 | Phillips Anne M. | director | A-Award | Acquired | 39,567 | $6.48 |
| 1 Jun 2026 | Chauche Thierry | Chief Financial Officer | A-Award | Acquired | 50,000 | $7.27 |
| 1 Jun 2026 | Grauer Andreas | Chief Medical Officer | A-Award | Acquired | 35,000 | $7.27 |
| 1 Jun 2026 | Rozek Elizabeth | Chief Legal & Admin. Officer | A-Award | Acquired | 100,000 | $7.27 |
| 1 Jun 2026 | Happel David | director, officer: President & CEO | A-Award | Acquired | 300,000 | $7.27 |